Patents by Inventor Chase Smith

Chase Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210290229
    Abstract: The present disclosure relates to a suture inventory management device that stores and dispenses individual units of sutures from a first compartment and stores boxes of units of sutures of the same type of sutures in a second compartment. In some embodiments, the suture inventory management device is a suture storage cart comprising suture storage systems. The suture storage systems including at least one pair of suture storage compartments, the pair of suture storage compartments comprising a bulk suture storage compartment and a suture unit storage compartment. Units of sutures are stored in the suture unit storage compartment and boxes of the same type of sutures are stored in the corresponding bulk suture storage compartments. The interior of the suture unit storage compartment has a hinged top lid transparent door that opens by sliding vertically and the bulk suture storage compartments are enclosed by transparent doors.
    Type: Application
    Filed: March 23, 2020
    Publication date: September 23, 2021
    Inventor: Chase Smith
  • Publication number: 20190374780
    Abstract: In one aspect, medical implant power sources employing reverse electrodialysis principles are described herein. For example, a power source for a medical implant comprises an anode and cathode adjacent to a membrane stack, the membrane stack comprising alternating anion and cation exchange membranes defining diluate and concentrate fluid compartments. The power source includes a first conduit for delivering a diluate blood stream to the one or more diluate fluid compartments and a second conduit for delivering a concentrate blood stream to the one or more concentrate fluid compartments, wherein the concentrate blood stream has an ionic concentration higher than the diluate blood stream.
    Type: Application
    Filed: September 11, 2017
    Publication date: December 12, 2019
    Inventors: Jamie HESTEKIN, Christa HESTEKIN, Chase SMITH, Brigitte RODGERS, Pedro Rafael Lima VIEIRA
  • Publication number: 20140163005
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are kinase inhibitors, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Application
    Filed: July 24, 2013
    Publication date: June 12, 2014
    Applicant: Forma Therapeutics, Inc.
    Inventors: KRISHNA MURTHI, REBECCA CASAUBON, ARTHUR F. KLUGE, CHASE SMITH, JOACHIM VOGT
  • Publication number: 20140163006
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are kinase inhibitors, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Application
    Filed: July 24, 2013
    Publication date: June 12, 2014
    Applicant: Forma Therapeutics, Inc.
    Inventors: KRISHNA MURTHI, REBECCA CASAUBON, ARTHUR F. KLUGE, CHASE SMITH, JOACHIM VOGT
  • Publication number: 20140163222
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are kinase inhibitors, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Application
    Filed: July 24, 2013
    Publication date: June 12, 2014
    Applicant: Forma Therapeutics, Inc.
    Inventors: KRISHNA MURTHI, REBECCA CASAUBON, ARTHUR F. KLUGE, CHASE SMITH, JOACHIM VOGT
  • Publication number: 20140163007
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are kinase inhibitors, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Application
    Filed: July 24, 2013
    Publication date: June 12, 2014
    Applicant: Forma Therapeutics, Inc.
    Inventors: KRISHNA MURTHI, REBECCA CASAUBON, ARTHUR F. KLUGE, CHASE SMITH, JOACHIM VOGT
  • Publication number: 20140163003
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are kinase inhibitors, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Application
    Filed: July 24, 2013
    Publication date: June 12, 2014
    Applicant: Forma Therapeutics, Inc.
    Inventors: KRISHNA MURTHI, REBECCA CASAUBON, ARTHUR F. KLUGE, CHASE SMITH, JOACHIM VOGT
  • Publication number: 20140163223
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are kinase inhibitors, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Application
    Filed: July 24, 2013
    Publication date: June 12, 2014
    Applicant: Forma Therapeutics, Inc.
    Inventors: KRISHNA MURTHI, REBECCA CASAUBON, ARTHUR F. KLUGE, CHASE SMITH, JOACHIM VOGT
  • Publication number: 20140163004
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are kinase inhibitors, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Application
    Filed: July 24, 2013
    Publication date: June 12, 2014
    Applicant: Forma Therapeutics, Inc.
    Inventors: KRISHNA MURTHI, REBECCA CASAUBON, ARTHUR F. KLUGE, CHASE SMITH, JOACHIM VOGT
  • Patent number: 8450348
    Abstract: The present invention provides derivatives of squaric acid, in particular derivatives of 3,4-diamino-cyclobut-3-ene-1,2-dione and tautomers and isomers thereof, as a single stereoisomer or a mixture of stereoisomers, or as a pharmaceutically acceptable salt thereof. These compounds show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Grant
    Filed: February 21, 2007
    Date of Patent: May 28, 2013
    Assignee: Forma TM, LLC
    Inventors: Krishna K. Murthi, Roland Köstler, Chase Smith, Tilman Brandstetter, Arthur F. Kluge
  • Patent number: 8232283
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are inhibitors or kinases such as Raf, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Grant
    Filed: May 12, 2011
    Date of Patent: July 31, 2012
    Assignee: Forma Therapeutics, Inc.
    Inventors: Andreas Schoop, Alexander Backes, Joachim Vogt, Lars Neumann, Jan Eickhoff, Stefan Hannus, Kerrin Hansen, Peter Amon, Igor Ivanov, Matthias Borgmann, Chase Smith, Arthur F. Kluge, Krishan Murthi, Rebecca Casaubon
  • Publication number: 20110257207
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are inhibitors or kinases such as Raf, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Application
    Filed: May 12, 2011
    Publication date: October 20, 2011
    Applicants: Agennix USA Inc, Agennix AG
    Inventors: Alexander BACKES, Joachim VOGT, Peter AMON, Igor IVANOV, Stefan HANNUS, Matthias BORGMANN, Kerrin HANSEN, Rebecca CASAUBON, Chase SMITH, Krishna MURTHI, Arthur KLUGE, Andreas SCHOOP, Lars NEUMANN, Jan EICKHOFF
  • Publication number: 20110201594
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are kinase inhibitors, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Application
    Filed: October 16, 2008
    Publication date: August 18, 2011
    Inventors: Krisna Murthi, Rebecca Casaubon, Arthur F. Kluge, Chase Smith, Joachim Vogt
  • Publication number: 20080200523
    Abstract: The present invention provides derivatives of squaric acid, in particular derivatives of 3,4-diamino-cyclobut-3-ene-1,2-dione and tautomers and isomers thereof, as a single stereoisomer or a mixture of stereoisomers, or as a pharmaceutically acceptable salt thereof. These compounds show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Application
    Filed: February 21, 2007
    Publication date: August 21, 2008
    Inventors: Krishna K. Murthi, Roland Kostler, Chase Smith, Tilman Brandstetter, Arthur F. Kluge
  • Patent number: 6861537
    Abstract: The synthesis of taxol and other tricyclic and tetracyclic taxanes.
    Type: Grant
    Filed: July 12, 2002
    Date of Patent: March 1, 2005
    Assignee: Florida State University
    Inventors: Robert A. Holton, Carmen Somoza, Hyeong Baik Kim, Mitsuru Shindo, Ronald J. Biediger, P. Douglas Boatman, Chase Smith, Feng Liang, Krishna Murthi
  • Patent number: 6433189
    Abstract: The synthesis of taxol and other tricyclic and tetracyclic taxanes.
    Type: Grant
    Filed: July 17, 2001
    Date of Patent: August 13, 2002
    Assignee: Florida State University
    Inventors: Robert A. Holton, Carmen Somoza, Hyeong Baik Kim, Mitsuru Shindo, Ronald J. Biediger, P. Douglas Boatman, Chase Smith, Feng Liang, Krishna Murthi
  • Patent number: 6278026
    Abstract: The synthesis of taxol and other tricyclic and tetracyclic taxanes.
    Type: Grant
    Filed: June 15, 1999
    Date of Patent: August 21, 2001
    Assignee: Florida State University
    Inventors: Robert A. Holton, Carmen Somoza, Hyeong Baik Kim, Mitsuru Shindo, Ronald J. Biediger, P. Douglas Boatman, Chase Smith, Feng Liang, Krishna Murthi
  • Patent number: 6005120
    Abstract: The synthesis of taxol and other tricyclic and tetracyclic taxanes.
    Type: Grant
    Filed: January 2, 1997
    Date of Patent: December 21, 1999
    Assignee: Florida State University
    Inventors: Robert A. Holton, Carmen Somoza, Hyeong Baik Kim, Mitsuru Shindo, Ronald J. Biediger, P. Douglas Boatman, Chase Smith, Feng Liang, Krishna Murthi
  • Patent number: 5760252
    Abstract: Process for the synthesis of taxol and other tricyclic and tetracyclic taxanes.
    Type: Grant
    Filed: December 19, 1996
    Date of Patent: June 2, 1998
    Assignee: Florida State University
    Inventors: Robert A. Holton, Carmen Somoza, Hyeong Baik Kim, Mitsuru Shindo, Ronald J. Biediger, P. Douglas Boatman, Chase Smith, Feng Liang, Krishna Murthi
  • Patent number: 5637732
    Abstract: The synthesis of taxol and other tricyclic and tetracyclic taxanes.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: June 10, 1997
    Assignee: Florida State University
    Inventors: Robert A. Holton, Carmen Somoza, Hyeong B. Kim, Mitsuru Shindo, Ronald J. Biediger, P. Douglas Boatman, Chase Smith, Feng Liang, Krishna Murthi